Mette Kristin Lund • 1959 • Greåker • 10 roles • 9 shareholdings

This website uses cookies to enhance the user experience.

Roles

Boards

Name	Role	Total operating income	Total equity	Shares
P PHARMAPAC AS	Board Member	-	29,518	50 % directly
V VITAMAX AS	Board Member	-	2,997,792	50 % indirectly
B BIOPHARMA AS	Board Member	24,069,305	5,582,290	40.31 % indirectly
P PHARMATECH AS	Alternate Member	404,181,231	21,362,866	40.31 % indirectly
B BIOSAN AS	Alternate Member	5,760,752	9,342,541	40.31 % indirectly
G GME LUND HOLDING AS	Chairman	-	15,881,277	40.31 % directly
M MULTILAB ØSTFOLD AS	Alternate Member	4,971,801	2,849,095	40.31 % indirectly
F FARMATEKET AS	Alternate Member	78,057	417,273	40.31 % indirectly
B BIO-SAN ANS	Participant with Joint and Several Liability (Full Responsibility)	-	-	-
L LAVENDULA ANS	Participant with Joint and Several Liability (Full Responsibility)	-	-	-

Last update: Apr 13, 2023

Related industries3

Wholesale and retail trade; repair of motor vehicles and motorcycles
Manufacturing
Professional, scientific and technical activities

Direct relationships4

Shares owned by Mette Kristin Lund

Name	Share class	Total operating income	Total equity	Share
P PHARMAPAC AS	Ordinære aksjer	0	29,518	50 % directly
V VITAMAX AS		0	2,997,792	50 % indirectly
G GME LUND HOLDING AS	Ordinære aksjer	0	15,881,277	40.31 % directly
B BIOPHARMA AS		24,069,305	5,582,290	40.31 % indirectly
P PHARMATECH AS		404,181,231	21,362,866	40.31 % indirectly
B BIOSAN AS		5,760,752	9,342,541	40.31 % indirectly
M MULTILAB ØSTFOLD AS		4,971,801	2,849,095	40.31 % indirectly
F FARMATEKET AS		78,057	417,273	40.31 % indirectly
L LUND EIENDOM FREDRIKSTAD AS		8,160,852	25,473,169	40.31 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024